Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV

por Cheng, Chien-Yu, Ku, Shin-Yen, Lin, Yi-Chun, Chen, Cheng-Pin, Cheng, Shu-Hsing, Lin, I-Feng
Publicado 2022

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901

por Estrada, Josue Antonio, Cheng, Chien-Yu, Ku, Shin-Yen, Hu, Hui-Chun, Yeh, Hsiu-Wen, Lin, Yi-Chun, Chen, Cheng-Pin, Cheng, Shu-Hsing, Janssen, Robert, Lin, I-Feng
Publicado 2022

Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial

por Lin, Yi-Chun, Li, Shih-Wei, Ku, Shin-Yen, Hsieh, Hui-Ting, Lin, Mei-Hui, Chang, Shu-Yin, Wu, Wei-Wei, Sun, Na-Lee, Cheng, Shu-Hsing, Cheng, Chien-Yu
Publicado 2019